Literature DB >> 21037909

Tacrolimus interaction with clotrimazole: a concise case report and literature review.

Mary Choy.   

Abstract

Entities:  

Keywords:  clotrimazole; tacrolimus; transplantation

Year:  2010        PMID： 21037909      PMCID： PMC2957750     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


× No keyword cloud information.
  13 in total

Review 1.  Biochemical, cellular, and pharmacological aspects of the multidrug transporter.

Authors:  S V Ambudkar; S Dey; C A Hrycyna; M Ramachandra; I Pastan; M M Gottesman
Journal:  Annu Rev Pharmacol Toxicol       Date:  1999       Impact factor: 13.820

2.  Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1997-09-15       Impact factor: 15.470

3.  Interaction between FK506 and clotrimazole in a liver transplant recipient.

Authors:  L Mieles; R Venkataramanan; I Yokoyama; V J Warty; T E Starzl
Journal:  Transplantation       Date:  1991-12       Impact factor: 4.939

4.  Proposal for a new tool to evaluate drug interaction cases.

Authors:  John R Horn; Philip D Hansten; Lingtak-Neander Chan
Journal:  Ann Pharmacother       Date:  2007-03-27       Impact factor: 3.154

5.  Acute tacrolimus nephrotoxicity in renal transplant patients treated with clarithromycin.

Authors:  G Gómez; M L Alvarez; P Errasti; F J Lavilla; N García; B Ballester; I García; A Purroy
Journal:  Transplant Proc       Date:  1999-09       Impact factor: 1.066

6.  Concomitant clotrimazole therapy more than doubles the relative oral bioavailability of tacrolimus.

Authors:  Eva M Vasquez; Grace P Shin; Nicole Sifontis; Enrico Benedetti
Journal:  Ther Drug Monit       Date:  2005-10       Impact factor: 3.681

7.  Clotrimazole increases tacrolimus blood levels: a drug interaction in kidney transplant patients.

Authors:  E Vasquez; R Pollak; E Benedetti
Journal:  Clin Transplant       Date:  2001-04       Impact factor: 2.863

8.  Unmasking the dynamic interplay between intestinal P-glycoprotein and CYP3A4.

Authors:  Carolyn L Cummins; Wolfgang Jacobsen; Leslie Z Benet
Journal:  J Pharmacol Exp Ther       Date:  2002-03       Impact factor: 4.030

9.  Diltiazem increases tacrolimus concentrations.

Authors:  M F Hebert; A Y Lam
Journal:  Ann Pharmacother       Date:  1999-06       Impact factor: 3.154

10.  Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine.

Authors:  K S Lown; R R Mayo; A B Leichtman; H L Hsiao; D K Turgeon; P Schmiedlin-Ren; M B Brown; W Guo; S J Rossi; L Z Benet; P B Watkins
Journal:  Clin Pharmacol Ther       Date:  1997-09       Impact factor: 6.875
View more
  2 in total

1.  Impact of the CYP3A5*1 Allele on the Pharmacokinetics of Tacrolimus in Japanese Heart Transplant Patients.

Authors:  Takaya Uno; Kyoichi Wada; Sachi Matsuda; Yuka Terada; Akira Oita; Atsushi Kawase; Mitsutaka Takada
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-12       Impact factor: 2.441

Review 2.  Drug Interactions between Antimicrobial and Immunosuppressive Agents in Solid Organ Transplant Recipients.

Authors:  Vikas Bhagat; Rahul A Pandit; Shwetha Ambapurkar; Manju Sengar; Atul P Kulkarni
Journal:  Indian J Crit Care Med       Date:  2021-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.